Dye-stabilized nanoparticles and methods of their manufacture and therapeutic use
AssigneeMemorial Sloan Kettering Cancer Center
InventorsDaniel A. HELLER, Yosef SHAMAY
Life of this patent
Estimating the term…
Loading patent…
AssigneeMemorial Sloan Kettering Cancer Center
InventorsDaniel A. HELLER, Yosef SHAMAY
Estimating the term…
Described herein are nanoparticles which are largely made of (e.g., 90 wt. %) hydrophobic drugs and are stabilized by water soluble dyes. The nanoparticles can range in size from 30 nm to 150 nm and have highly negative surface charge (e.g., −55 mV). These nanoparticles are highly soluble in water, stable for days in PBS buffer and can be easily lyophilzed and reconstituted in water. Using quantitative self-assembly prediction calculations, topochemical molecular descriptors were identified and validated as highly predictive indicators of nano-assembly, nanoparticle size, and drug loading. The resulting nanoparticles selectively targeted kinase inhibitors to caveolin-1-expressing human colon cancer and autochthonous liver cancer models to yield striking therapeutic effects while avoiding pERK inhibition in healthy skin. The nanoparticles exhibited remarkable anti-tumor efficacy in vitro and in vivo in models of hepatocellular carcinoma.
A dye-stabilized nanoparticle composition comprising
5-6. (canceled)
(canceled)
12-14. (canceled)
17-18. (canceled)
(canceled)
A method for predicting self-assembly of a dye-stabilized nanoparticle composition, the method comprising
28-37. (canceled)
Dependencies are inferred from the claim text.